News Daily News High Restenosis Rate After CTO Bailout Technique Linked to Suboptimal Flow September 15, 2015
News Conference News ESC 2015 ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff September 09, 2015
News Conference News ESC 2015 FREEDOM Substudy: CABG, PCI Outcomes Affected by Baseline BP Yael L. Maxwell August 30, 2015
News Conference News ESC 2015 CIRCUS: Transplant Rejection Drug Fails to Reduce Infarct Size in Anterior STEMI L.A. McKeown August 30, 2015
News Daily News Registry Study Suggests Absorb BVS Matches DES in Diabetic All-Comers August 27, 2015
News Industry News BioControl Medical Completes Enrollment in the INOVATE-HF Study of the CardioFit® System to Treat Heart Failure August 27, 2015
News Daily News No Disadvantage for 2-Stent Strategy in Bifurcation Lesions With Second-Generation DES Yael L. Maxwell August 26, 2015
News Daily News International Study Links Treatment Variations to Mortality in Acute MI Yael L. Maxwell August 14, 2015
News Daily News BARI 2D: Increased Risk Factor Control in Patients With Type 2 Diabetes Ups Survival Yael L. Maxwell August 12, 2015
News Industry News Tryton Medical Announces Completion of Enrollment in the EXTENDED ACCESS Registry for its Tryton Side Branch Stent August 03, 2015
News Features Opportunities Exist for Hospitals, Interventionalists to Stave Off Unnecessary Readmissions July 28, 2015
News Industry News Navidea and Massachusetts General Hospital to Evaluate Manocept™ for Detection of Cardiovascular Disease with NIH Grant July 28, 2015
News Industry News Regeneron and Sanofi Announce CHMP Recommends European Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia July 24, 2015
News Industry News Positive Clinical Data From Lp(a) Lowering Drug ISIS-APO(a) Rx Published in The Lancet July 23, 2015
News Daily News Registry Provides Reassurance About Rotational Atherectomy Pre-PCI Todd Neale July 23, 2015
News Industry News European Commission Approves Amgen's New Cholesterol-Lowering Medication Repatha™ (evolocumab), The First PCSK9 Inhibitor To Be Approved In The World, For Treatment Of High Cholesterol July 21, 2015